Patents by Inventor Laure Navarre

Laure Navarre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MONOHYDRATE POTASSIUM SALT OF A THIENOPYRIDONE DERIVATIVE AND ITS PREPARATION PROCESS
    Publication number: 20220017532
    Abstract: The invention relates to a process for preparing a monohydrate potassium salt of a 5 thienopyridone derivative. It also relates to a monohydrate potassium salt of a thienopyridone derivative and its use in medicine, in particular for treating or preventing metabolic disorders, such as NASH.
    Type: Application
    Filed: November 18, 2019
    Publication date: January 20, 2022
    Inventors: SÉBASTIEN BOLZE, MARC LANZ, DENIZ ARICAN, ANTHONY O'SULLIVAN, SOPHIE HALLAKOU-BOZEC, LAURE NAVARRE
  • Process for preparing R-gossypol L-phenylalaninol dienamine
    Patent number: 7696372
    Abstract: This invention relates to a process for preparing R-gossypol L-phenylalaninol dienamine using non-chromatographic purification methods. In particular, the invention is directed to resolution of R- and S-gossypol L-phenylalaninol dienamine by crystallization. R-gossypol L-phenylalaninol dienamine is a useful intermediate for the preparation of R-(?)-gossypol and R-(?)-gossypol acetic acid co-crystal. R-(?)-Gossypol acetic acid and its co-crystal is useful for inducing apoptosis in cells and for sensitizing cells to the induction of apoptotic cell death.
    Type: Grant
    Filed: October 1, 2008
    Date of Patent: April 13, 2010
    Assignee: Ascenta Therapeutics, Inc.
    Inventors: Ming Guo, Shuguang Zhu, Laure Navarre, Régis Périon
  • Process for preparing R-gossypol L-Phenylalaninol dienamine
    Publication number: 20090088590
    Abstract: This invention relates to a process for preparing R-gossypol L-phenylalaninol dienamine using non-chromatographic purification methods. In particular, the invention is directed to resolution of R- and S-gossypol L-phenylalaninol dienamine by crystallization. R-gossypol L-phenylalaninol dienamine is a useful intermediate for the preparation of R-(?)-gossypol and R-(?)-gossypol acetic acid co-crystal. R-(?)-Gossypol acetic acid and its co-crystal is useful for inducing apoptosis in cells and for sensitizing cells to the induction of apoptotic cell death.
    Type: Application
    Filed: October 1, 2008
    Publication date: April 2, 2009
    Applicant: Ascenta Therapeutics, Inc.
    Inventors: Ming Guo, Shuguang Zhu, Laure Navarre, Regis Perion